MRNA
Moderna Inc
NASDAQ: MRNA · HEALTHCARE · BIOTECHNOLOGY
$45.72
-3.01% today
Updated 2026-04-29
Market cap
$18.13B
P/E ratio
—
P/S ratio
9.33x
EPS (TTM)
$-7.26
Dividend yield
—
52W range
$22 – $60
Volume
7.5M
Moderna Inc (MRNA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-145.20%
Operating margin
-126.40%
ROE
-28.90%
ROA
-14.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $500000.00 | $-6.48M | 100.00% | -704.00% | -1,295.40% |
| 2015 | $0.00 | $-1.11M | — | — | — |
| 2016 | $108.40M | $-216.21M | 86.06% | -206.44% | -199.46% |
| 2017 | $205.82M | $-255.92M | 90.02% | -130.87% | -124.34% |
| 2018 | $122.51M | $-384.73M | -270.64% | -337.33% | -314.04% |
| 2019 | $48.04M | $-514.02M | 100.00% | -1,136.06% | -1,070.07% |
| 2020 | $274.49M | $-747.06M | 97.11% | -278.02% | -272.16% |
| 2021 | $17.74B | $12.20B | 85.24% | 74.97% | 68.80% |
| 2022 | $18.88B | $8.36B | 71.31% | 49.91% | 44.30% |
| 2023 | $6.85B | $-4.71B | 31.47% | -61.90% | -68.84% |
| 2024 | $3.20B | $-3.56B | 54.24% | -123.32% | -111.32% |
| 2025 | $1.94B | $-2.82B | 55.35% | -158.13% | -145.16% |